GE HealthCare Moves StarGuide GX 4D SPECT/CT Toward FDA Clearance

{
  "signal_id": "86b94698-a576-7763-858c-16ba1708e52b",
  "signal_type": "news",
  "signal_subtype": "is_developing",
  "detected_at": "2026-09-09T16:04:00+00:00",
  "company": {
    "name": "GE HealthCare",
    "domain": "gehealthcare.com"
  },
  "data": {
    "url": "https://finance.yahoo.com/healthcare/articles/ge-healthcare-moves-starguide-gx-160400475.html",
    "title": "GE HealthCare Moves StarGuide GX 4D SPECT/CT Toward FDA Clearance - Yahoo Finance",
    "excerpt": "GE HealthCare Technologies Inc. GEHC recently announced that it is taking its next-generation StarGuide GX digital 4D cadmium zinc telluride (CZT) SPECT/CT system closer to the U.S. market with the submission to the FDA for 510(k) clearance. Following its recent CE Mark, the milestone marks continued progress toward expanding access to next-generation molecular imaging technologies and supporting a broader range of nuclear medicine applications. Per Jean-Luc Procaccini, president and CEO, Molecular Imaging and Computed Tomography, GE HealthCare, the company is focused on innovation that anticipates the evolving needs of healthcare and provides clinicians with advanced technologies. With StarGuide GX now 510(k) pending in the United States and CE-Marked in Europe, GEHC is advancing next-generation molecular imaging solutions to support the expansion of theranostics and precision care. The technology is designed to help clinicians adopt emerging tracers, broaden clinical applications and deliver more personalized patient care. Following the announcement, GEHC stock lost 3% at yesterday's close. Year to date, shares of the company have fallen 18.6% compared with the industry's 20.6% decline. However, the S&P 500 has risen 11.6% in the same timeframe. The regulatory progress of StarGuide GX could strengthen GE HealthCare's position in the growing molecular imaging market as demand...",
    "product": "StarGuide GX",
    "summary": "GE HealthCare has submitted its next-generation StarGuide GX digital 4D SPECT/CT system to the FDA for 510(k) clearance, moving it closer to the U.S. market.",
    "location": "United States",
    "planning": true,
    "image_url": "https://s.yimg.com/lo/mysterio/api/eaa8b31b2577c15cf02333746d695271c2e40af6de0eb80a2499d1dad04738de/lightyear_networkapi/resizefill_w1200%3Bquality_80%3Bformat_webp/https%3A%2F%2Fmedia.zenfs.com%2Fen%2Fzacks.com%2Ff1ab23713eb4abd14ac0da3ac5667420.jpg",
    "confidence": 0.9,
    "product_data": {
      "name": "StarGuide GX",
      "full_text": "next-generation StarGuide GX digital 4D cadmium zinc telluride (CZT) SPECT/CT system",
      "fuzzy_match": false,
      "release_type": "system"
    },
    "product_tags": [
      "medical",
      "general_technology"
    ],
    "published_at": "2026-09-09T16:04:00Z",
    "location_data": [
      {
        "region": "Northern America",
        "country": "United States",
        "continent": "Americas",
        "fuzzy_match": false
      }
    ],
    "vulnerability": "FDA 510(k) clearance submission",
    "article_sentence": "GE HealthCare Technologies Inc. GEHC recently announced that it is taking its next-generation StarGuide GX digital 4D cadmium zinc telluride (CZT) SPECT/CT system closer to the U.S. market with the submission to the FDA for 510(k) clearance.",
    "related_company_name": "Food and Drug Administration",
    "related_company_domain": "fda.gov"
  }
}

curl https://signals.autobound.ai/v1/signals/86b94698-a576-7763-858c-16ba1708e52b \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"gehealthcare.com","limit":20}'